AUPO652897A0 - Synthetic peptide constructs for the diagnosis and treatment of periodontitis - Google Patents

Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Info

Publication number
AUPO652897A0
AUPO652897A0 AUPO6528A AUPO652897A AUPO652897A0 AU PO652897 A0 AUPO652897 A0 AU PO652897A0 AU PO6528 A AUPO6528 A AU PO6528A AU PO652897 A AUPO652897 A AU PO652897A AU PO652897 A0 AUPO652897 A0 AU PO652897A0
Authority
AU
Australia
Prior art keywords
periodontitis
diagnosis
treatment
synthetic peptide
peptide constructs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPO6528A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Victorian Dairy Industry Authority
University of Melbourne
Original Assignee
Victorian Dairy Industry Authority
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victorian Dairy Industry Authority, University of Melbourne filed Critical Victorian Dairy Industry Authority
Priority to AUPO6528A priority Critical patent/AUPO652897A0/en
Publication of AUPO652897A0 publication Critical patent/AUPO652897A0/en
Priority to CA2815903A priority patent/CA2815903A1/en
Priority to EP08010103.3A priority patent/EP1985625B1/en
Priority to CA002288234A priority patent/CA2288234C/en
Priority to DK98916667T priority patent/DK1017714T3/da
Priority to JP54641598A priority patent/JP4276300B2/ja
Priority to EP98916667A priority patent/EP1017714B1/en
Priority to CA2639048A priority patent/CA2639048C/en
Priority to KR1019997010041A priority patent/KR100356040B1/ko
Priority to NZ500451A priority patent/NZ500451A/en
Priority to ES08010103T priority patent/ES2530510T3/es
Priority to EP10171207A priority patent/EP2246361A1/en
Priority to CA2720332A priority patent/CA2720332C/en
Priority to AU70169/98A priority patent/AU735956B2/en
Priority to PCT/AU1998/000311 priority patent/WO1998049192A1/en
Priority to DE69840027T priority patent/DE69840027D1/de
Priority to AT98916667T priority patent/ATE408618T1/de
Priority to US10/387,977 priority patent/US7262271B2/en
Priority to US11/731,307 priority patent/US7749502B2/en
Priority to US12/797,566 priority patent/US8431688B2/en
Priority to US13/852,272 priority patent/US8841420B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AUPO6528A 1997-04-30 1997-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis Abandoned AUPO652897A0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
AUPO6528A AUPO652897A0 (en) 1997-04-30 1997-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AT98916667T ATE408618T1 (de) 1997-04-30 1998-04-30 Synthetische peptidkonstrukte zur erkennung und behandlung von parodontose hervorgerufen durch porphyromonas gingivalis
ES08010103T ES2530510T3 (es) 1997-04-30 1998-04-30 Constructos peptídicos sintéticos para el diagnóstico y tratamiento de periodontitis asociada con Porphyromonas gingivalis
CA2720332A CA2720332C (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
CA002288234A CA2288234C (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
DK98916667T DK1017714T3 (da) 1997-04-30 1998-04-30 Syntetiske peptidkonstruktioner til diagnose og behandling af paradentose forbundet med porphyromonas gingivalis
JP54641598A JP4276300B2 (ja) 1997-04-30 1998-04-30 Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓに関連した歯周病の診断および治療のための合成ペプチド構築物
EP98916667A EP1017714B1 (en) 1997-04-30 1998-04-30 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
CA2639048A CA2639048C (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
KR1019997010041A KR100356040B1 (ko) 1997-04-30 1998-04-30 포피로모나스 긴기발리스 관련 치주염의 진단 및 치료용 합성 펩타이드 구조체
NZ500451A NZ500451A (en) 1997-04-30 1998-04-30 Peptide constructs derived from porphyromonas gingivalis protein for use in treating periodontitis
CA2815903A CA2815903A1 (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
EP10171207A EP2246361A1 (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis
EP08010103.3A EP1985625B1 (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
AU70169/98A AU735956B2 (en) 1997-04-30 1998-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
PCT/AU1998/000311 WO1998049192A1 (en) 1997-04-30 1998-04-30 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS)
DE69840027T DE69840027D1 (de) 1997-04-30 1998-04-30 Synthetische peptidkonstrukte zur erkennung und behandlung von parodontose hervorgerufen durch porphyromonas gingivalis
US10/387,977 US7262271B2 (en) 1997-04-30 2003-03-12 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
US11/731,307 US7749502B2 (en) 1997-04-30 2007-03-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis
US12/797,566 US8431688B2 (en) 1997-04-30 2010-06-09 Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with Porphyromonas gingivalis
US13/852,272 US8841420B2 (en) 1997-04-30 2013-03-28 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPO6528A AUPO652897A0 (en) 1997-04-30 1997-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Publications (1)

Publication Number Publication Date
AUPO652897A0 true AUPO652897A0 (en) 1997-05-29

Family

ID=3800820

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPO6528A Abandoned AUPO652897A0 (en) 1997-04-30 1997-04-30 Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Country Status (12)

Country Link
US (4) US7262271B2 (enExample)
EP (3) EP1985625B1 (enExample)
JP (1) JP4276300B2 (enExample)
KR (1) KR100356040B1 (enExample)
AT (1) ATE408618T1 (enExample)
AU (1) AUPO652897A0 (enExample)
CA (4) CA2639048C (enExample)
DE (1) DE69840027D1 (enExample)
DK (1) DK1017714T3 (enExample)
ES (1) ES2530510T3 (enExample)
NZ (1) NZ500451A (enExample)
WO (1) WO1998049192A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
DK2256205T3 (da) * 1997-12-10 2013-07-08 Csl Ltd Porphorymonas gingivalis-polypeptider og -polynukleotider
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
US20070053923A1 (en) * 2003-01-30 2007-03-08 Ki-Seok Park Dna vaccine composition with enhanced immunogenicity
NZ554331A (en) * 2004-09-23 2009-04-30 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
JP2009544279A (ja) 2006-06-27 2009-12-17 オーラル ヘルス オーストラリア ピーティーワイ リミテッド 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド
CN101842486A (zh) * 2007-07-12 2010-09-22 口腔健康澳洲私人有限公司 生物膜的免疫治疗
ES2432690T3 (es) * 2007-07-12 2013-12-04 Oral Health Australia Pty Ltd Tratamiento de biopelícula
US8142764B2 (en) 2008-02-27 2012-03-27 University Of Louisville Research Foundation Synthetic biofilm-inhibiting peptides
WO2010022463A1 (en) 2008-08-29 2010-03-04 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
MY162557A (en) 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
BR112019005935A2 (pt) 2016-09-29 2019-06-11 Meharry Medical College inibidores bacterianos
CN113419059B (zh) * 2021-06-30 2023-09-01 迈克生物股份有限公司 用于化学发光免疫分析方法的封闭剂
WO2025019900A1 (en) * 2023-07-26 2025-01-30 Denteric Pty Ltd Chimeric protein vaccine

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210035A (en) 1980-05-19 1993-05-11 Board Of Trustees Of Leland Stanford Jr. University Non-reventing live vaccines
US4837151A (en) 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US4735801A (en) 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
JPS60142915A (ja) * 1983-12-28 1985-07-29 Lion Corp 口腔用組成物
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
AU557164B2 (en) * 1984-03-30 1986-12-11 Otsuka Kagaku Kabushiki Kaisha Preparation of fibrous alkali metal titanate
JPH0699291B2 (ja) * 1985-06-14 1994-12-07 ライオン株式会社 口腔用組成物
US5013542A (en) * 1988-02-08 1991-05-07 Forsyth Dental Infirmary For Children Method to inhibit adhesion of disease-causing microorganisms to teeth
IT8820888A0 (it) * 1988-06-08 1988-06-08 Eniricerche Spa Peptidi di sintesi immunologicamente attivi per lapreparazione di vaccini antimalarici.
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5824791A (en) * 1988-09-08 1998-10-20 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
US5665559A (en) * 1989-05-18 1997-09-09 The United States Of America As Represented By The Secretary Of The Navy Production of monoclonal antibodies to bacteroides gingivalis by hybridoma BGII, VF9/2D
DE4324859A1 (de) * 1992-07-23 1994-01-27 Lion Corp Oral verabreichbare Zusammensetzung zur Behandlung periodontaler Erkrankungen
US5536497A (en) * 1992-12-21 1996-07-16 The Research Foundation Of State University Of New York Fimbrial polypeptides useful in the prevention of periodontitis
JPH08508240A (ja) * 1993-01-12 1996-09-03 ジョージ グリスティーナ，アンソニー 受動免疫の直接的濃厚伝達のための方法および組成物
WO1995000110A1 (en) * 1993-06-28 1995-01-05 Lion Corporation Composition for oral cavity
US6017532A (en) 1993-09-10 2000-01-25 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
EP0717747B1 (en) * 1993-09-10 2003-06-04 The University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase coding sequences
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
JPH0797395A (ja) 1993-09-28 1995-04-11 Kyowa Medex Co Ltd ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途
JPH09511220A (ja) * 1993-11-10 1997-11-11 ブリストル‐マイヤーズ スクイブ カンパニー バクテリアによって誘発される炎症性疾患の治療
EP0753577B1 (en) 1994-03-29 2002-07-24 Kyowa Hakko Kogyo Co., Ltd. Cell-surface polypeptide gene
FI98961C (fi) * 1994-08-26 1997-09-10 Medix Biochemica Ab Oy Menetelmät ja määritysvälineet parodontaalisairauden aktiivisuuden ja/tai peri-implantiitin ja/tai niiden kohonneen riskin diagnosoimiseksi
US20030157637A1 (en) * 1998-09-15 2003-08-21 The University Of Melbourne Diagnostics and treatments of periodontal disease
AUPN627595A0 (en) 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
US6129917A (en) * 1996-03-22 2000-10-10 The University Of Georgia Research Foundation, Inc. Immunogenic compositions comprising porphyromonas gingivalis proteins and/or peptides and methods
AUPN901296A0 (en) * 1996-03-29 1996-04-26 University Of Melbourne, The Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
US7341727B1 (en) 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
AUPP083997A0 (en) 1997-12-10 1998-01-08 Csl Limited Porphyromonas gingivalis nucleotides
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
US6444799B1 (en) 1997-12-31 2002-09-03 Csl Limited P. gingivalis polynucleotides and uses thereof
AUPP893999A0 (en) 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
US6833262B1 (en) * 1999-04-21 2004-12-21 University Of Georgia Research Foundation, Inc. Polypeptide having amidolytic activity for a serpin
CA2373447A1 (en) 1999-05-12 2000-11-16 The General Hospital Corporation Permeabilizing biofilms
GB9913437D0 (en) 1999-06-09 1999-08-11 Medical Res Council Fusion proteins
AUPQ485999A0 (en) 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
US20020110843A1 (en) * 2000-05-12 2002-08-15 Dumas David P. Compositions and methods for epitope mapping
AU2002225954A1 (en) * 2000-11-08 2002-05-21 The University Of Georgia Research Foundation, Inc. Dipeptidylpeptidases and methods of use
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US20030083287A1 (en) 2000-11-30 2003-05-01 Burgess Nicola A. ginS
US20020192206A1 (en) * 2001-05-05 2002-12-19 Kozarov Emil V. Methods and compositions for angioproliferative disorder treatment
AUPR575401A0 (en) 2001-06-18 2001-07-12 Unisearch Limited Method of causing sloughing
JP2003192616A (ja) 2001-12-27 2003-07-09 Univ Nihon 歯周病用ｄｎａワクチン
JP2003286191A (ja) 2002-03-27 2003-10-07 Univ Nihon 歯周病用粘膜免疫ワクチン
US20070036734A1 (en) 2003-03-17 2007-02-15 Kirin Beer Kabushiki Kaisha Therapeutic agent for periodontal disease
DE602004031024D1 (de) 2003-08-15 2011-02-24 Univ Florida Die identifikation von polynukleotiden von porphyromonas gingivalis-virulenz zur diagnose, behandlung und beobachtung von periodontalerkrankungen
EP1721283B1 (en) 2004-02-06 2022-11-30 Council of Scientific and Industrial Research Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential
US20070098649A1 (en) 2004-03-22 2007-05-03 The Board Of Trustees Of The University Of Illinois Method and composition for controlling oral pathogens
NZ554331A (en) 2004-09-23 2009-04-30 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
WO2008016385A2 (en) 2006-01-20 2008-02-07 The University Of Washington Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
JP2009544279A (ja) 2006-06-27 2009-12-17 オーラル ヘルス オーストラリア ピーティーワイ リミテッド 歯周病の予防に有用なポルフィロモナス・ジンジバリスポリペプチド
WO2008124646A2 (en) 2007-04-06 2008-10-16 The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services Use of amyloid proteins as vaccine scaffolds
CN101842486A (zh) 2007-07-12 2010-09-22 口腔健康澳洲私人有限公司 生物膜的免疫治疗
ES2432690T3 (es) 2007-07-12 2013-12-04 Oral Health Australia Pty Ltd Tratamiento de biopelícula
KR100948094B1 (ko) 2007-12-26 2010-03-16 주식회사 하이닉스반도체 데이터 출력 제어회로
WO2010022463A1 (en) 2008-08-29 2010-03-04 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of p.gingivalis infection

Also Published As

Publication number Publication date
CA2639048A1 (en) 1998-11-05
US8431688B2 (en) 2013-04-30
EP1017714A4 (en) 2005-02-23
EP1985625B1 (en) 2014-11-12
EP1017714A1 (en) 2000-07-12
US20130309179A1 (en) 2013-11-21
DE69840027D1 (de) 2008-10-30
US20080124284A1 (en) 2008-05-29
CA2288234A1 (en) 1998-11-05
NZ500451A (en) 2001-02-23
EP2246361A1 (en) 2010-11-03
JP2002511847A (ja) 2002-04-16
EP1985625A2 (en) 2008-10-29
KR20010020417A (ko) 2001-03-15
US8841420B2 (en) 2014-09-23
US20110268670A1 (en) 2011-11-03
EP1985625A3 (en) 2009-02-18
CA2288234C (en) 2008-11-18
US20040005276A1 (en) 2004-01-08
US7749502B2 (en) 2010-07-06
CA2720332A1 (en) 1998-11-05
US7262271B2 (en) 2007-08-28
ATE408618T1 (de) 2008-10-15
DK1017714T3 (da) 2009-01-05
JP4276300B2 (ja) 2009-06-10
CA2720332C (en) 2013-07-23
CA2815903A1 (en) 1998-11-05
ES2530510T3 (es) 2015-03-03
KR100356040B1 (ko) 2002-10-18
CA2639048C (en) 2012-12-11
EP1017714B1 (en) 2008-09-17
WO1998049192A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
AUPO652897A0 (en) Synthetic peptide constructs for the diagnosis and treatment of periodontitis
MY101842A (en) Treatment of oral diseases.
AU2834292A (en) Oral composition having improved tooth whitening effect
MX9803648A (es) Composiciones y metodos para mejorar el desempeño de productos cosmeticos de uso prolongado.
AU623555B2 (en) Disinfecting compositions and methods therefor
AU7573496A (en) Prophylactic immune milk preparation against otitis
NL300433I1 (en) Methods and compositions for the treatment of glomerulonephritis
ZA874549B (en) Compositions containing usnic acid or its derivatives for the therapeutical control of dental caries,particularly for the treatment of the cariogenic dental plaque
AR020169A1 (es) Uso de una bacteria lactica para la preparacion de composiciones orales, las composiciones para la salud de la boca que contienen dicha bacteria lactica yel metodo para seleccionar bacterias lacticas de aplicacion en dicho uso
KR950702405A (ko) 구강 조성물(oral compositions)
CA2200977A1 (en) Aqueous oral compositions
ZA972757B (en) Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.
IE39303B1 (en) Compositions for oral hygiene
De Graaff et al. The role of Actinobacillus actinomycetemcomitans in periodontal disease
GB9501826D0 (en) Polypeptide fragments
MY117939A (en) Composition for enhancing oral hygiene
UA43399C2 (uk) Композиція для гігієни, профілактики і лікування захворювань порожнини рота
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
JPS5569507A (en) Composition for oral cavity application
BG102890A (en) Vaccine for mammals of the feline family containing chlamydia prittaci, and a method for its preparation
GB9814648D0 (en) Sub-lethal perfumes
DE69119588D1 (de) Verwendung von ketorolac zur behandlung von periodontitis
ATE93134T1 (de) Orale praeparate.
MY125752A (en) Caries-preventive dentifrice composition